Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.63 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | APEX1 | P27695 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL4467558 | 0.99 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL28335299 | 0.99 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL7162432 | 0.99 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| Histidine SCHEMBL25236169 | 0.95 | CYP3A4 (0.74) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL1537285 | 0.91 | CYP3A4 (0.71) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL163444 | 0.91 | CYP3A4 (0.71) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| Hydrochloric Acid SCHEMBL28331180 | 0.89 | CYP3A4 (0.69) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| Sulfuric Acid SCHEMBL28796991 | 0.89 | CYP3A4 (0.61) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL10666465 | 0.89 | CYP3A4 (0.60) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 | |
| SCHEMBL28328192 | 0.88 | CYP3A4 (0.67) | CYP3A4SLC7A5HRH4HRH3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2315 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125458-A1 | BISPECIFIC ANTI-VEGF/ANG2 ANTIBODY FORMULATION | HOFFMANN-LA ROCHE INC. (US) | 2026-05-07 | — | — | US | claimed |
| US-20260083671-A1 | STABILIZED FORMULATION COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN | GBIOLOGICS INC (KR) | 2026-03-26 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260055178-A1 | ANTIBODY FORMULATIONS | GENENTECH INC (US) | 2026-02-26 | — | — | US | claimed |
| EP-4688854-A2 | METHODS OF TREATING TUMORS WITH ANTI-TIGIT ANTIBODIES | Genentech, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260028395-A1 | TREATMENT OF OPHTHALMOLOGIC DISEASES | GENENTECH, INC. (US) | 2026-01-29 | — | — | US | claimed |
| EP-4681729-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PD-1/PVRIG/TIGIT BINDING PROTEIN AND MEDICAL USE THEREOF | Shanghai Mabgen Biotech Ltd. (CN) | 2026-01-21 | — | — | EP | claimed |
| US-20250388677-A1 | ANTI-PDL1 ANTIBODY FORMULATIONS | GENENTECH, INC. (US) | 2025-12-25 | — | — | US | claimed |
| US-12503503-B2 | Bispecific anti-VEGF/ANG2 antibody formulation | HOFFMANN-LA ROCHE INC. (US) | 2025-12-23 | — | — | US | claimed |
| EP-4663183-A1 | STABILIZED FORMULATION COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN | Gbiologics Inc. (KR) | 2025-12-17 | — | — | EP | claimed |
| CN-101084015-A | Antibody formulations in histidine-acetate buffer | GENENTECH INC (US) | 2007-12-05 | — | — | CN | claimed |
| EP-1838735-A2 | POLYPEPTIDES THAT BIND BR3 AND USES THEREOF | GENENTECH, INC. (US) | 2007-10-03 | — | — | EP | claimed |
| WO-2006073941-A9 | POLYPEPTIDES THAT BIND BR3 AND USES THEREOF | GENENTECH INC (US) | 2007-07-05 | — | — | WO | claimed |
| EP-1802344-A2 | ANTIBODY FORMULATION IN HISTIDINE-ACETATE BUFFER | Genentech, Inc. (US) | 2007-07-04 | — | — | EP | claimed |
| WO-2006073941-A2 | POLYPEPTIDES THAT BIND BR3 AND USES THEREOF | GENENTECH, INC. (US) | 2006-07-13 | — | — | WO | claimed |
| US-20060088523-A1 | Antibody formulations | GENENTECH, INC. | 2006-04-27 | — | — | US | claimed |
| WO-2006044908-A2 | ANTIBODY FORMULATION IN HISTIDINE-ACETATE BUFFER | GENENTECH, INC. (US) | 2006-04-27 | — | — | WO | claimed |
| EP-1578449-A2 | COMPOSITIONS OF BENZOQUINOLIZINE CARBOXYLIC ACID ANTIBIOTIC DRUGS | Wockhardt Limited (IN) | 2005-09-28 | — | — | EP | claimed |
| US-20040176321-A1 | Compositions of benzoquinolizine carboxylic acid antibiotic drugs | WOCKHARDT LIMITED | 2004-09-09 | — | — | US | claimed |
| WO-2004058303-A2 | COMPOSITIONS OF BENZOQUINOLIZINE CARBOXYLIC ACID ANTIBIOTIC DRUGS | WOCKHARDT LIMITED (IN) | 2004-07-15 | — | — | WO | claimed |